Landos Biopharma Receives Notice Of Allowance For U.S. Patent Titled ‘NLRX1 LIGANDS (TO TREAT MANY CONDITIONS INCLUDING ALZHEIMER’S DISEASE AND PARKINSON’S DISEASE)’
https://patentcenter.uspto.gov/#!/applications/17479337/ifw/docs
Raymond James Is Bearish On This Inflammatory Bowel Disease Player On Upcoming ‘Pipeline Reset’
Raymond James downgraded Landos Biopharma Inc (NASDAQ:LABP) to Market Perform from Outperform following 2Q22 earnings and the first look at NX-13…
Recap Of Wednesday’s Biotech Catalysts – End Of the Day Summary
The U.S. Food and Drug Administration (FDA) has accepted for review MediWound’s (NASDAQ:MDWD) recently re-submitted Biologics License Application…
This Healthcare Stock Jumps Around 188%, Here’s 83 Biggest Movers From Yesterday
Gainers
Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.
Why Is NeuroSense Therapeutics Surging by 70%? 46 Stocks Moving In Monday’s Mid-Day Session
Gainers
Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 87.3% to $0.6965 amid the Supreme Court overturning Roe V Wade.
7 Hot Upcoming IPOs to Watch For in 2022
There were a record 1,035 IPOs on the U.S. stock market in 2021. Of these, 159 have returned profits to investors.
This means that last year, an investor had a 15.36% chance of investing in an IPO that would generate returns. Of the highest returning IPOs of 2021, some include:
56 Stocks Moving In Friday’s Mid-Day Session
Gainers
Veru Inc. (NASDAQ: VERU) shares jumped 62.5% to $14.67 after the company reported quarterly results on Thursday. Jefferies maintained Veru with a Buy and raised the price target from $33 to $55.
Landos Biopharma Q1 EPS $(0.37) Up From $(0.38) YoY
Landos Biopharma (NASDAQ:LABP) reported quarterly losses of $(0.37) per share. This is a 2.63 percent increase over losses of $(0.38) per share from the same period last year.
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 211 companies set new 52-week lows.